Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results.
about
Estimated HIV incidence in the United States, 2006-2009Evaluation of HIV incidence surveillance in New York City, 2006HIV-1 transmission during early infection in men who have sex with men: a phylodynamic analysisMeasuring the HIV/AIDS epidemic: approaches and challenges.Interpopulation variation in HIV testing promptness may introduce bias in HIV incidence estimates using the serologic testing algorithm for recent HIV seroconversion.Is back-projection methodology still relevant for estimating HIV incidence from national surveillance data?Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco.Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay.Cost-effectiveness of strategies to improve HIV testing and receipt of results: economic analysis of a randomized controlled trial.Bootstrap confidence intervals and bias correction in the estimation of HIV incidence from surveillance data with testing for recent infection.Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trialEstimation of HIV incidence in the United States.HIV incidence estimate combining HIV/AIDS surveillance, testing history information and HIV test to identify recent infections in Lazio, Italy.Estimated HIV Incidence in California, 2006-2009High percentage of recent HIV infection among HIV-positive individuals newly diagnosed at voluntary counseling and testing sites in Poland.Association of brain-type natriuretic protein and cardiac troponin I with incipient cardiovascular disease in chimpanzees (Pan troglodytes)HIV Transmission Rates in the United States, 2006-2008.Trends of HIV-1 incidence with credible intervals in Sweden 2002-09 reconstructed using a dynamic model of within-patient IgG growthMean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.HIV Incidence Estimates Using the Limiting Antigen Avidity EIA Assay at Testing Sites in Kiev City, Ukraine: 2013-2014.Stochastic models to demonstrate the effect of motivated testing on HIV incidence estimates using the serological testing algorithm for recent HIV seroconversion (STARHS)Estimating the distribution of the window period for recent HIV infections: a comparison of statistical methods.A Bayesian hierarchical model with novel prior specifications for estimating HIV testing ratesEstimation of HIV incidence in two Brazilian municipalities, 2013.HIV Trends in the United States: Diagnoses and Estimated Incidence.Estimates of HIV-1 incidence based on serological methods: a brief methodological review.HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay.A Flow-Based Model of the HIV Care Continuum in the United States.Determining the likely place of HIV acquisition for migrants in Europe combining subject-specific information and biomarkers data.
P2860
Q21135528-42292789-C5EC-4E62-B551-2C6D0D1033F9Q28385222-7C823537-1E54-49B8-A910-6DACBAEAA7E1Q28536682-71F81698-2D28-4FC6-BD27-940DF17F5D8EQ30386305-756224FD-084F-44F7-B480-947287EEAE49Q30524062-5377AFFA-7CB8-48E2-88D6-6B669C9003F7Q30572713-72340858-9558-41C3-9D69-9A4F1E687AB1Q33604727-AA10F748-8985-44B3-80D4-AC64B871B878Q33719217-D0166E39-8002-430B-B7DC-D4B16B73852DQ33848933-96A5658F-A1A4-485C-9318-47781B0EF595Q33854227-2A30EF7F-F8E5-49F2-A23E-AD35DD9EF984Q34041659-BF9A11C1-C971-4382-A9C9-44F72F818190Q34056420-6D16904D-9467-4CC6-821B-6E3209C3516BQ34203609-214573F0-3E33-4B19-9152-9DFE5E40259AQ34584051-13B19FC8-55D0-451A-9775-5B59D5A67A84Q34647528-32374A5D-5E7B-43C7-889D-1864A10EF684Q34820013-2B055A53-FB1E-42ED-B2BC-78895F4866C2Q35871958-1C86D5CC-674B-4C3F-BCDF-E16D124BC73AQ35905630-B3CD2386-C3EB-4272-8989-A37ECBF41F60Q35985816-D31CD2B7-094B-4B5B-A467-21C7C0A74265Q36045124-07052C46-8357-48CF-A67A-55B9B68A6804Q36182422-92B66359-BB52-41E6-8BCB-7E89A5729F56Q36316124-5DC10F0B-CF49-42F1-956F-6AC5B72D64EFQ36835894-C16C7180-41B4-45D0-8E65-E7D5E0AF9D3DQ37211397-02B11513-175A-453E-93D5-F1435DF82993Q37650724-A0730B30-45EE-4043-A4A5-46F07CC81ECFQ37866660-62AE79DD-9F4E-4019-B3A9-13CA42921064Q38649701-29192463-EBEA-45B7-8F0D-B9595C0109F4Q38804734-1155053E-AA6E-488F-B73E-AB1723AD3418Q47323125-95E6B8F1-5423-4877-B2DE-C898267EC6ED
P2860
Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Estimating HIV incidence in th ...... nd biomarker HIV test results.
@ast
Estimating HIV incidence in th ...... nd biomarker HIV test results.
@en
type
label
Estimating HIV incidence in th ...... nd biomarker HIV test results.
@ast
Estimating HIV incidence in th ...... nd biomarker HIV test results.
@en
prefLabel
Estimating HIV incidence in th ...... nd biomarker HIV test results.
@ast
Estimating HIV incidence in th ...... nd biomarker HIV test results.
@en
P2093
P356
P1476
Estimating HIV incidence in th ...... nd biomarker HIV test results.
@en
P2093
H Irene Hall
John M Karon
Ruiguang Song
P304
P356
10.1002/SIM.3144
P407
P577
2008-10-01T00:00:00Z